Nuvaira has developed the Nuvaira Lung Denervation System to treat patients with chronic obstructive pulmonary disease (COPD) refractory to drug therapy.
Location: United States, Minnesota, Minneapolis
Total raised: $79M
Investors 2
| Date | Name | Website |
| - | US Venture... | usvp.com |
| - | Lightstone... | lightstone... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.02.2019 | - | $79M | - |
Mentions in press and media 14
| Date | Title | Description |
| 11.08.2021 | Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone USA - English España - español France - Français Deutschland - Deutsch | |
| 23.11.2020 | Nuvaira Announces Published Two-Year Results in COPD Patients treated with Targeted Lung Denervation USA - English France - Français Deutschland - Deutsch España - español | |
| 21.07.2020 | Seattle-area medical device startup CurvaFix raises $10.7M for curved bone implant tech | Medical device startup CurvaFix raised $10.7 million to spur development of its technology that helps repair fractures in curved bones. The Bellevue, Wash.-based company is preparing to commercialize its CurvaFix Rodscrew system, an alterna... |
| 13.02.2019 | Minneapolis-Based Nuvaira Raises $79 Million To Fight Chronic Lung Diseases | Nuvaira, a Minneapolis, Minnesota-based developer of novel therapeutic medical devices for treating obstructive lung diseases, has raised $79 million in funding led by U.S. Venture Partners. Endeavour Vision, Qiming Venture Partners, Lights... |
| 13.02.2019 | Term Sheet — Wednesday, February 13 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop — Missing a headliner such a WeWork is worse than investing in 100 companies on the highway to failure. That’s the... |
| 12.02.2019 | Daily funding roundup - February 12th, 2019 | Zoovu $14M; Chainalysis raised $16M; Second Measure raised $20M; Nuvaira raised $79M iFarm Project: Farm develops an innovative technology to grow natural salads, berries and vegetables year-round in fully controlled automated environment. ... |
| 12.02.2019 | Nuvaira Announces a $79M Financing | MINNEAPOLIS, MN, Nuvaira, a developer of novel therapeutic medical devices to treat obstructive lung diseases, announced today it has closed a $79 million equity financing. >> Click here for more funding data on Nuvaira >> T... |
| 11.02.2019 | Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD | - |
| 11.02.2019 | Top startup news for today, Monday, February 11, 2019 | Good morning! Here are some of the top technology startup news stories for today, Monday, February 11. Fitbit unveils a new health tracker that is only available through your employer or insurer. Fitbit quietly launches Inspire, its first ... |
| 11.02.2019 | Nuvaira raises $79M for lung nerve ablation procedure for COPD and asthma | Nuvaira has raised $79 million in equity financing to continue late-stage clinical development of its device-based treatment for chronic obstructive pulmonary disease in the U.S. The Minneapolis-based company’s minimally invasive, one-time ... |
Show more